Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
Quick Stats
Jul 02, 202650.0
AI Score
HOLD0.68
Volume Ratio
Aug 04, 2026
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
MYGN Stock Summary
Last updated Jul 02, 2026
MYGN is currently trading at $5.99, positioned above its 200-day moving average of $5.79, indicating a long-term uptrend. The stock has a 52-week range of $3.53 to $8.59.
Technical Analysis: The 50-day moving average stands at $4.52, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 73.173, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.302, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MYGN at 50.0/100 with a HOLD recommendation.
MYGN (Myriad Genetics Inc) Indicators
Last updated Jul 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 73.173 |
| CMF (20) | 0.302 |
| ROC (10) | 36.758 |
| ADX (14) | 34.798 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.429 |
| AROONOSC (14) | 85.714 |
| WILLAMS %R (14) | -6.731 |
| MFI (14) | 80.965 |
MYGN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MYGN Price vs Max Options Open Interest
MYGN Max Change In Options Open Interest
MYGN Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MYGN Daily Out of Money Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MYGN Daily In the Money Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MYGN Most Active Options by Volume(near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Myriad Genetics Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MYGN Moving Averages Analysis
Myriad Genetics Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 02, 2026
Myriad Genetics Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 02, 2026
MYGN (Myriad Genetics Inc) Simple Moving Averages
Moving Averages are last updated Jul 02, 2026
| Days | MA |
|---|---|
| 10 | 5.38 |
| 20 | 4.91 |
| 30 | 4.63 |
| 50 | 4.52 |
| 100 | 4.63 |
| 200 | 5.79 |
MYGN Fundamental Analysis
| P/E (Forward) | 54.0541 |
| P/E (Trailing) | -- |
| Market Cap ($) | 566.7 million |
| Earnings/Share ($) | -4.31 |
| Net Proft Margin (%) | -0.4129 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.0478 |
| EPS Estimate Next Year ($) | 0.1511 |
| WallStreet Target Price ($) | 6.25 |
| Most Recent Quarter |